Clinical Trials Browser

Enrolling by invitation × OTHER × toripalimab × Clear all

NCT06882876 2025-09-19

JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study

Phase 1 Enrolling by invitation

Gastrointestinal

Carcinoma, Hepatocellular